Ovarian Cancer Therapy
Oita University reports research in ovarian cancer therapy
Published in Cancer Weekly, March 30th, 2010
A report, 'PK11195 enhances chemosensitivity to cisplatin and paclitaxel in human endometrial and ovarian cancer cells,' is newly published data in International Journal of Molecular Medicine. "The potential anticancer agent 1-(2-chlorophenyl-N-methylpropyl)-3-isoquinolinecarboxamide (PK11195), a translocator protein ligand, facilitates the induction of cell death by a variety of cytotoxic and chemotherapeutic agents in various human tumor cell lines. The purpose of this study was to elucidate the effect of PK11195 on three endometrial cancer cell lines, two ovarian cancer cell lines and normal human endometrial epithelial cells," scientists writing in the International Journal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2010-03-30)
More Articles from Cancer Weekly
- American Society for Radiation Oncology
ASTRO publishes supplement on protecting cancer patients by reducing radiation doses, side effects - BMJ-British Medical Journal
Omega 3 curbs precancerous growths in those prone to bowel cancer - Elsevier
Childhood adversity may promote cellular aging - Emory University
Late-stage melanoma results in economic burden - Fox Chase Cancer Center
Some clinical trials explicitly exclude gay and lesbian patients - JAMA and Archives Journals
Although most cancer centers have palliative care programs, scope of services varies widely - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
